The leading cause of cancer-related death in the United States is lung cancer. According to a study published in the Journal of Nuclear Medicine in January, roughly half of Medicare patients with Non-Small Cell Lung Cancer (NSCLC) do not receive the appropriate imaging before radiation treatment.

Research has shown that up to 72 percent of patients with lung cancer who receive NSCLC with FDG PET/CT imaging have seen various treatment changes. Compared to patients who underwent CT imaging alone, patients with FDG PET/CT imaging had substantially improved cancer-specific survival rates.

As a result, National Comprehensive Cancer Network (NCCN) guidelines have changed to suggest all recurrent NSCLC patients receive FDG PET/CT to evaluate for metastatic disease.

The study conducted by researchers examined over 5,000 patients with NSCLC requiring radiation therapy. Those who received only CT imaging were in one group, and those who received additional FDG PET/CT were in another. Scientists investigated the overall and cancer-specific survival rates of both groups.

When comparing survival rates after three years, those who received only CT imaging had substantially lower overall and cancer-specific survival rates compared to patients who underwent FDG PET/CT imaging.

In total, 56.3 percent of patients experienced FDG PET/CT before radiation therapy, and 43.6 percent had CT imaging alone.

Rustain Morgan, MD, MS, a nuclear radiologist at the University of Colorado in Aurora, Colorado, said, This research shows a clear lack of adherence to guidelines and raises important questions as to why. We believe these findings are the tip of the iceberg for guideline nonadherence. More work needs to be done in order to better understand the scope of the issue, with further work focused on interventions which ensure guideline adherence. _____________________________________

RadParts, a TTG Imaging Solutions Company, is the world s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerators and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost components and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/

• New Discovery in Matter-Antimatter Asymmetry
• Compact, Cost-Effective Laser-Powered Particle Accelerators: A Game Changer for the Industry
• Prenuvo Launches FDA-Cleared AI-Powered Whole Body MRI Screening Products
• Linear Particle Accelerators Market: A Thriving Industry with Expanding Horizons
• Prevention and Screening: Major Contributors to Saving Lives in Five Key Cancer Types
• Can AI Improve Early Detection of Breast Cancer in MRI Studies?
• BAT: A Revolutionary Garment Enhancing Radiation Safety for Healthcare Professionals
• Research Advocates for Advanced Precision Radiation Therapy in Lung Cancer
• Advancements in Lung Cancer Detection and Treatment Monitoring
• Diagnosing Multiple Sclerosis (MS)